Search

everythinglearnresearchcommunity

for

Search:↓

Plasmalogens activate a channel in cells that may stimulate hair growth.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Some alternative therapies for vitiligo show promise but need more research.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Topical vitamin D is effective in treating vitiligo with few side effects.

Chamomile extract can protect hair from damage caused by light.

The KRTAP7-1 gene is very similar across different cattle and yak breeds and likely plays a role in hair strength and shape.

Susan Lee Lindquist was a pioneering biologist who made significant contributions to understanding protein folding and its role in disease.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Researchers identified potential markers for human hair color stem cells.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Warfarin can rarely cause hair loss, which is usually reversible.

Nerve growth factor helps cashmere goat hair cells grow and is more active during the hair growth phase.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

Teak is a durable, termite-resistant wood with medicinal benefits.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Silk proteins are great for cosmetics because they protect and improve skin and hair while being eco-friendly.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.